Biogen Escapes 1 Of 4 FCA Suits Over Alleged Kickbacks
By John Kennedy ( February 3, 2016, 8:01 PM EST) -- One of four whistleblower complaints accusing Biogen Inc. of violating the False Claims Act by paying millions of dollars in kickbacks to doctors as incentives and rewards for prescribing the company's multiple sclerosis drugs to Medicare patients was voluntarily dismissed from Massachusetts federal court Wednesday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.